FAM234B

gene
On this page

Summary

FAM234B (family with sequence similarity 234 member B, HGNC:29288) is a protein-coding gene on chromosome 12p13.1, encoding Protein FAM234B (A2RU67).

Predicted to be located in Golgi apparatus; membrane; and microtubule organizing center.

Source: NCBI Gene 57613 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 103 total
  • MANE Select transcript: NM_020853

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29288
Approved symbolFAM234B
Namefamily with sequence similarity 234 member B
Location12p13.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000084444
Ensembl biotypeprotein_coding
OMIM617838
Entrez57613

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 3 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined

ENST00000197268, ENST00000416494, ENST00000535974, ENST00000537625, ENST00000540455, ENST00000541950, ENST00000893327

RefSeq mRNA: 1 — MANE Select: NM_020853 NM_020853

CCDS: CCDS31750

Canonical transcript exons

ENST00000197268 — 13 exons

ExonStartEnd
ENSE000007219521306664013066787
ENSE000007219531306715513067296
ENSE000011219591307978913080009
ENSE000014102271308062513083449
ENSE000014203201304438113044440
ENSE000016364721305845113058549
ENSE000016427431305555113055946
ENSE000017308361306157513061763
ENSE000017626381306284513062975
ENSE000034660501307124113071396
ENSE000035300781306863013068711
ENSE000035340291307602613076143
ENSE000036071271306830413068447

Expression profiles

Bgee: expression breadth ubiquitous, 237 present calls, max score 96.26.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.9345 / max 196.0223, expressed in 1658 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1244017.83281658
1243992.92531314
1244000.101757

Top tissues by expression

284 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
lateral nuclear group of thalamusUBERON:000273696.26gold quality
CA1 field of hippocampusUBERON:000388194.27gold quality
olfactory bulbUBERON:000226494.15gold quality
substantia nigra pars compactaUBERON:000196594.10gold quality
type B pancreatic cellCL:000016994.07gold quality
orbitofrontal cortexUBERON:000416793.29gold quality
Brodmann (1909) area 46UBERON:000648393.00gold quality
parietal lobeUBERON:000187292.79gold quality
middle temporal gyrusUBERON:000277192.55gold quality
postcentral gyrusUBERON:000258192.53gold quality
superior frontal gyrusUBERON:000266192.41gold quality
substantia nigra pars reticulataUBERON:000196691.84gold quality
lateral globus pallidusUBERON:000247691.72gold quality
ventral tegmental areaUBERON:000269190.64gold quality
prefrontal cortexUBERON:000045190.61gold quality
ponsUBERON:000098890.43gold quality
Brodmann (1909) area 10UBERON:001354190.39gold quality
superior vestibular nucleusUBERON:000722790.19gold quality
dorsal motor nucleus of vagus nerveUBERON:000287090.08gold quality
hair follicleUBERON:000207389.89gold quality
cortical plateUBERON:000534389.80gold quality
entorhinal cortexUBERON:000272889.79gold quality
occipital lobeUBERON:000202189.70gold quality
frontal cortexUBERON:000187089.61gold quality
dorsal plus ventral thalamusUBERON:000189789.38gold quality
Brodmann (1909) area 23UBERON:001355489.21gold quality
medulla oblongataUBERON:000189688.97gold quality
Brodmann (1909) area 9UBERON:001354088.90gold quality
dorsolateral prefrontal cortexUBERON:000983488.66gold quality
neocortexUBERON:000195088.61gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.22
E-GEOD-124858no160.27

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

148 targeting FAM234B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-8485100.0077.574731
HSA-MIR-3163100.0077.238605
HSA-MIR-432-3P100.0067.86705
HSA-MIR-12118100.0065.881270
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-318599.9968.121959
HSA-MIR-186-5P99.9970.833707
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-373-5P99.9875.364753
HSA-MIR-616-5P99.9875.584775
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-570-3P99.9672.414910
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-651-3P99.9473.485177
HSA-MIR-205-3P99.9269.923165
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-345-3P99.8970.231421
HSA-MIR-990299.8969.152250
HSA-MIR-394199.8670.542735
HSA-MIR-4728-5P99.8569.394718

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriofam234bENSDARG00000006758
mus_musculusFam234bENSMUSG00000030207
rattus_norvegicusFam234bENSRNOG00000008443
drosophila_melanogasterCG3618FBGN0037028
drosophila_melanogasterCG6184FBGN0038725

Paralogs (1): FAM234A (ENSG00000167930)

Protein

Protein identifiers

Protein FAM234BA2RU67 (reviewed: A2RU67)

All UniProt accessions (2): A2RU67, Q69YM1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane. Golgi outpost. Cytoplasm. Cytoskeleton. Microtubule organizing center.

Similarity. Belongs to the FAM234 family.

RefSeq proteins (1): NP_065904* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR011047Quinoprotein_ADH-like_sfHomologous_superfamily
IPR045232FAM234Family
IPR055409Beta-prop_FAM234A_BDomain

Pfam: PF23727

UniProt features (12 total): modified residue 5, sequence conflict 4, chain 1, transmembrane region 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A2RU67-F178.270.46

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 16, 26, 30, 33, 62

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 148 (showing top): BROWNE_HCMV_INFECTION_16HR_UP, GOCC_MICROTUBULE_ORGANIZING_CENTER, SMID_BREAST_CANCER_LUMINAL_B_UP, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, MODULE_48, MODULE_95, NUYTTEN_EZH2_TARGETS_DN, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C, LU_EZH2_TARGETS_DN, CHYLA_CBFA2T3_TARGETS_DN, BILANGES_SERUM_SENSITIVE_VIA_TSC2, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7, KRIEG_HYPOXIA_NOT_VIA_KDM3A

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (5): microtubule organizing center (GO:0005815), membrane (GO:0016020), cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
binding1
microtubule cytoskeleton1
intracellular anatomical structure1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
intracellular membraneless organelle1

Protein interactions and networks

STRING

452 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM234BLURAP1Q96LR2497
FAM234BTM9SF2Q99805494
FAM234BLRRIQ3A6PVS8479
FAM234BAMZ2Q86W34447
FAM234BMANSC1Q9H8J5447
FAM234BC12orf60Q5U649435
FAM234BGLG1Q92896433
FAM234BCREBL2O60519406
FAM234BMBOAT2Q6ZWT7395
FAM234BOR4C11Q6IEV9393
FAM234BZNF552Q9H707393
FAM234BHID1Q8IV36390
FAM234BNKAIN3Q8N8D7385
FAM234BPRELID2Q8N945385
FAM234BMYO18AQ92614383

IntAct

40 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
TRDNTMEM223psi-mi:“MI:0914”(association)0.640
FAM234BABCD4psi-mi:“MI:0914”(association)0.620
ABCD4FAM234Bpsi-mi:“MI:0915”(physical association)0.620
SCGB1D1FAM234Bpsi-mi:“MI:0914”(association)0.530
XKRXFAM234Bpsi-mi:“MI:0914”(association)0.530
FRMD5FAM234Bpsi-mi:“MI:0914”(association)0.530
ANKHFAM234Bpsi-mi:“MI:0914”(association)0.530
STX12FAM234Bpsi-mi:“MI:0914”(association)0.530
SEC22BNBASpsi-mi:“MI:0914”(association)0.350
STX12NBASpsi-mi:“MI:0914”(association)0.350
FRMD3FAM234Bpsi-mi:“MI:0914”(association)0.350
CANXHLA-Apsi-mi:“MI:0914”(association)0.350
BET1NBASpsi-mi:“MI:0914”(association)0.350
ST8SIA4FAM234Bpsi-mi:“MI:0914”(association)0.350
CSGALNACT1FAM234Bpsi-mi:“MI:0914”(association)0.350
GINM1FAM234Bpsi-mi:“MI:0914”(association)0.350
MPPE1FAM234Bpsi-mi:“MI:0914”(association)0.350
ZACNFAM234Bpsi-mi:“MI:0914”(association)0.350

BioGRID (120): KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), KIAA1467 (Affinity Capture-MS), DEPDC1 (Affinity Capture-MS), ABCD4 (Affinity Capture-MS), FRMD5 (Affinity Capture-MS), SLC25A51 (Affinity Capture-MS), TMEM214 (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2KQY6, A0A6I8PMZ8, A0JPN2, A2RU67, A4IGY6, A5D7L5, D3ZWJ9, L5KLU7, O08644, O08721, O08722, O15197, P0C0K7, P0DX17, Q08E40, Q15043, Q1KZG0, Q4V887, Q504Y0, Q58Y75, Q5FVQ0, Q5FWH7, Q5M936, Q5RAB7, Q640M6, Q642A7, Q6L8F3, Q6P5W5, Q6PEH9, Q6ZN44, Q75N73, Q76MJ5, Q78IQ7, Q7TNJ2, Q8BYI8, Q8C0Z1, Q8IZJ1, Q8IZY2, Q8K1S4, Q8WTR4

Diamond homologs: A2RU67, D3ZWJ9, Q5F3L3, Q8BYI8, Q2HJE5, Q8C0Z1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

103 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance72
Likely benign13
Benign6

Top pathogenic / likely-pathogenic (0)

SpliceAI

2538 predictions. Top by Δscore:

VariantEffectΔscore
12:13044436:GCCGG:Gdonor_gain1.0000
12:13044437:CCGGG:Cdonor_loss1.0000
12:13044438:CGGG:Cdonor_loss1.0000
12:13044439:GG:Gdonor_gain1.0000
12:13044439:GGGT:Gdonor_loss1.0000
12:13044440:GG:Gdonor_gain1.0000
12:13044440:GGTA:Gdonor_loss1.0000
12:13044441:G:Tdonor_loss1.0000
12:13044442:T:Adonor_loss1.0000
12:13055549:A:AGacceptor_gain1.0000
12:13055549:AG:Aacceptor_gain1.0000
12:13055550:G:GGacceptor_gain1.0000
12:13055550:GG:Gacceptor_gain1.0000
12:13055942:GGGAG:Gdonor_gain1.0000
12:13055943:GGAGG:Gdonor_gain1.0000
12:13055944:G:Tdonor_gain1.0000
12:13058546:GTAG:Gdonor_gain1.0000
12:13061571:TTA:Tacceptor_loss1.0000
12:13061572:TAG:Tacceptor_loss1.0000
12:13062885:C:CAacceptor_gain1.0000
12:13062974:AGGTA:Adonor_loss1.0000
12:13062976:G:Tdonor_loss1.0000
12:13062977:T:Gdonor_loss1.0000
12:13066638:A:AGacceptor_gain1.0000
12:13066639:G:GGacceptor_gain1.0000
12:13066639:GCC:Gacceptor_gain1.0000
12:13066639:GCCA:Gacceptor_gain1.0000
12:13066788:G:GGdonor_gain1.0000
12:13066789:T:Gdonor_loss1.0000
12:13068302:A:AGacceptor_gain1.0000

AlphaMissense

3997 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
12:13055577:T:CY22H0.997
12:13044423:G:TR7M0.996
12:13044429:T:AL9H0.996
12:13055578:A:GY22C0.994
12:13055601:A:CS30R0.994
12:13055603:T:AS30R0.994
12:13055603:T:GS30R0.994
12:13055921:G:CW136C0.994
12:13055921:G:TW136C0.994
12:13067247:T:AW365R0.994
12:13067247:T:CW365R0.994
12:13044424:G:CR7S0.992
12:13044424:G:TR7S0.992
12:13076072:T:CL524P0.992
12:13044423:G:CR7T0.991
12:13067249:G:CW365C0.991
12:13067249:G:TW365C0.991
12:13079825:T:AV560D0.990
12:13044429:T:CL9P0.989
12:13055874:T:CC121R0.989
12:13055919:T:AW136R0.988
12:13055919:T:CW136R0.988
12:13067166:G:CA338P0.988
12:13079989:T:CF615L0.988
12:13079991:T:AF615L0.988
12:13079991:T:GF615L0.988
12:13044408:C:TA2V0.987
12:13079990:T:CF615S0.987
12:13055880:T:CF123L0.986
12:13055882:C:AF123L0.986

dbSNP variants (sampled 300 via entrez): RS1000009124 (12:13065443 C>T), RS1000047894 (12:13079314 T>A,C), RS1000113649 (12:13072468 A>C,T), RS1000235216 (12:13072139 G>C), RS1000316852 (12:13070902 C>A,T), RS1000341065 (12:13047690 T>G), RS1000440455 (12:13064532 C>A,T), RS1000474250 (12:13081328 C>G), RS1000582572 (12:13072820 C>T), RS1000617765 (12:13077335 A>G), RS1000649186 (12:13071162 C>T), RS1000797126 (12:13048018 GA>G,GAA), RS1000810102 (12:13065857 A>G), RS1000842331 (12:13059193 G>A,T), RS1000855025 (12:13052808 T>C)

Disease associations

OMIM: gene MIM:617838 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST012490_253Femur bone mineral density x serum urate levels interaction9.000000e-09

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004531urate measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

33 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, increases expression5
bisphenol Aincreases expression2
Nickeldecreases expression2
Tetrachlorodibenzodioxindecreases expression2
FR900359increases phosphorylation1
bisphenol Faffects cotreatment, increases expression1
dicrotophosincreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
coumarinaffects phosphorylation1
abrinedecreases expression1
Sunitinibincreases expression1
Air Pollutants, Occupationalaffects expression1
Atrazineincreases expression1
Benzo(a)pyreneaffects methylation1
Calcitriolincreases expression1
Cyclophosphamideaffects cotreatment, affects response to substance1
Dexamethasoneaffects cotreatment, increases expression1
Diethylstilbestrolincreases expression1
Doxorubicinaffects cotreatment, affects response to substance1
Estradioldecreases expression1
Fluorouracilaffects cotreatment, affects response to substance1
Folic Aciddecreases expression1
Indomethacinaffects cotreatment, increases expression1
Quercetinincreases phosphorylation1
Thimerosaldecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Triclosandecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.